 | • レポートコード：D0GIR-01535 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、CISインスリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。CISインスリンの種類別市場規模（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン）、用途別市場規模（I型・その他糖尿病、II型糖尿病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Boehringer Ingelheim、Sanofi Aventis、Novo Nordisk、Merck、Takeda Pharmaceuticals、Oramed Pharmaceuticals、Nanjing Xinbai Pharmaceutical、Biocon ・地域別グローバル市場分析 2015年-2020年 ・CISインスリンの北米市場（アメリカ、カナダ、メキシコ） ・CISインスリンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CISインスリンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CISインスリンの南米市場（ブラジル、アルゼンチン） ・CISインスリンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン ・用途別分析：I型・その他糖尿病、II型糖尿病 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global CIS Insulin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The CIS Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
CIS Insulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, CIS Insulin market has been segmented into:
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
By Application, CIS Insulin has been segmented into:
Type I and Other Diabetes
Type II Diabetes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CIS Insulin market presented in the report. This section sheds light on the sales growth of different regional and country-level CIS Insulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CIS Insulin market.
The report offers in-depth assessment of the growth and other aspects of the CIS Insulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and CIS Insulin Market Share Analysis
CIS Insulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CIS Insulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CIS Insulin sales, revenue and market share for each player covered in this report.
The major players covered in CIS Insulin are:
Eli Lilly
Boehringer Ingelheim
Sanofi Aventis
Novo Nordisk
Merck
Takeda Pharmaceuticals
Oramed Pharmaceuticals
Nanjing Xinbai Pharmaceutical
Biocon
Table of Contents
1 CIS Insulin Market Overview
1.1 Product Overview and Scope of CIS Insulin
1.2 Classification of CIS Insulin by Type
1.2.1 Global CIS Insulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CIS Insulin Revenue Market Share by Type in 2019
1.2.3 Long-Acting Analog
1.2.4 Rapid Acting Analog
1.2.5 Premixed Analog
1.2.6 Intermediate Insulin
1.2.7 Short Acting Insulin
1.2.8 Premixed Insulin
1.3 Global CIS Insulin Market by Application
1.3.1 Overview: Global CIS Insulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Global CIS Insulin Market by Regions
1.4.1 Global CIS Insulin Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CIS Insulin (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CIS Insulin Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CIS Insulin Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CIS Insulin Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CIS Insulin Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CIS Insulin Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Boehringer Ingelheim SWOT Analysis
2.2.4 Boehringer Ingelheim Product and Services
2.2.5 Boehringer Ingelheim CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi Aventis
2.3.1 Sanofi Aventis Details
2.3.2 Sanofi Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi Aventis SWOT Analysis
2.3.4 Sanofi Aventis Product and Services
2.3.5 Sanofi Aventis CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novo Nordisk SWOT Analysis
2.4.4 Novo Nordisk Product and Services
2.4.5 Novo Nordisk CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda Pharmaceuticals
2.6.1 Takeda Pharmaceuticals Details
2.6.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda Pharmaceuticals SWOT Analysis
2.6.4 Takeda Pharmaceuticals Product and Services
2.6.5 Takeda Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.7 Oramed Pharmaceuticals
2.7.1 Oramed Pharmaceuticals Details
2.7.2 Oramed Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Oramed Pharmaceuticals SWOT Analysis
2.7.4 Oramed Pharmaceuticals Product and Services
2.7.5 Oramed Pharmaceuticals CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nanjing Xinbai Pharmaceutical
2.8.1 Nanjing Xinbai Pharmaceutical Details
2.8.2 Nanjing Xinbai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Nanjing Xinbai Pharmaceutical SWOT Analysis
2.8.4 Nanjing Xinbai Pharmaceutical Product and Services
2.8.5 Nanjing Xinbai Pharmaceutical CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocon SWOT Analysis
2.9.4 Biocon Product and Services
2.9.5 Biocon CIS Insulin Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CIS Insulin Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CIS Insulin Players Market Share
3.2.2 Top 10 CIS Insulin Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CIS Insulin Revenue and Market Share by Regions
4.2 North America CIS Insulin Revenue and Growth Rate (2015-2020)
4.3 Europe CIS Insulin Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CIS Insulin Revenue and Growth Rate (2015-2020)
4.5 South America CIS Insulin Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CIS Insulin Revenue and Growth Rate (2015-2020)
5 North America CIS Insulin Revenue by Countries
5.1 North America CIS Insulin Revenue by Countries (2015-2020)
5.2 USA CIS Insulin Revenue and Growth Rate (2015-2020)
5.3 Canada CIS Insulin Revenue and Growth Rate (2015-2020)
5.4 Mexico CIS Insulin Revenue and Growth Rate (2015-2020)
6 Europe CIS Insulin Revenue by Countries
6.1 Europe CIS Insulin Revenue by Countries (2015-2020)
6.2 Germany CIS Insulin Revenue and Growth Rate (2015-2020)
6.3 UK CIS Insulin Revenue and Growth Rate (2015-2020)
6.4 France CIS Insulin Revenue and Growth Rate (2015-2020)
6.5 Russia CIS Insulin Revenue and Growth Rate (2015-2020)
6.6 Italy CIS Insulin Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CIS Insulin Revenue by Countries
7.1 Asia-Pacific CIS Insulin Revenue by Countries (2015-2020)
7.2 China CIS Insulin Revenue and Growth Rate (2015-2020)
7.3 Japan CIS Insulin Revenue and Growth Rate (2015-2020)
7.4 Korea CIS Insulin Revenue and Growth Rate (2015-2020)
7.5 India CIS Insulin Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CIS Insulin Revenue and Growth Rate (2015-2020)
8 South America CIS Insulin Revenue by Countries
8.1 South America CIS Insulin Revenue by Countries (2015-2020)
8.2 Brazil CIS Insulin Revenue and Growth Rate (2015-2020)
8.3 Argentina CIS Insulin Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CIS Insulin by Countries
9.1 Middle East & Africa CIS Insulin Revenue by Countries (2015-2020)
9.2 Saudi Arabia CIS Insulin Revenue and Growth Rate (2015-2020)
9.3 UAE CIS Insulin Revenue and Growth Rate (2015-2020)
9.4 Egypt CIS Insulin Revenue and Growth Rate (2015-2020)
9.5 South Africa CIS Insulin Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CIS Insulin Revenue and Market Share by Type (2015-2020)
10.2 Global CIS Insulin Market Forecast by Type (2019-2024)
10.3 Long-Acting Analog Revenue Growth Rate (2015-2025)
10.4 Rapid Acting Analog Revenue Growth Rate (2015-2025)
10.5 Premixed Analog Revenue Growth Rate (2015-2025)
10.6 Intermediate Insulin Revenue Growth Rate (2015-2025)
10.7 Short Acting Insulin Revenue Growth Rate (2015-2025)
10.8 Premixed Insulin Revenue Growth Rate (2015-2025)
11 Global CIS Insulin Market Segment by Application
11.1 Global CIS Insulin Revenue Market Share by Application (2015-2020)
11.2 CIS Insulin Market Forecast by Application (2019-2024)
11.3 Type I and Other Diabetes Revenue Growth (2015-2020)
11.4 Type II Diabetes Revenue Growth (2015-2020)
12 Global CIS Insulin Market Size Forecast (2021-2025)
12.1 Global CIS Insulin Market Size Forecast (2021-2025)
12.2 Global CIS Insulin Market Forecast by Regions (2021-2025)
12.3 North America CIS Insulin Revenue Market Forecast (2021-2025)
12.4 Europe CIS Insulin Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CIS Insulin Revenue Market Forecast (2021-2025)
12.6 South America CIS Insulin Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CIS Insulin Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global CIS Insulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CIS Insulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CIS Insulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market CIS Insulin Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly CIS Insulin Major Business
Table 7. Eli Lilly CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly CIS Insulin Product and Solutions
Table 10. Eli Lilly CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 12. Boehringer Ingelheim CIS Insulin Major Business
Table 13. Boehringer Ingelheim CIS Insulin Total Revenue (USD Million) (2018-2019)
Table 14. Boehringer Ingelheim SWOT Analysis
Table 15. Boehringer Ingelheim CIS Insulin Product and Solutions
Table 16. Boehringer Ingelheim CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Aventis Corporate Information, Location and Competitors
Table 18. Sanofi Aventis CIS Insulin Major Business
Table 19. Sanofi Aventis CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi Aventis SWOT Analysis
Table 21. Sanofi Aventis CIS Insulin Product and Solutions
Table 22. Sanofi Aventis CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novo Nordisk Corporate Information, Location and Competitors
Table 24. Novo Nordisk CIS Insulin Major Business
Table 25. Novo Nordisk CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 26. Novo Nordisk SWOT Analysis
Table 27. Novo Nordisk CIS Insulin Product and Solutions
Table 28. Novo Nordisk CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck CIS Insulin Major Business
Table 31. Merck CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck CIS Insulin Product and Solutions
Table 34. Merck CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Takeda Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Takeda Pharmaceuticals CIS Insulin Major Business
Table 37. Takeda Pharmaceuticals CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 38. Takeda Pharmaceuticals SWOT Analysis
Table 39. Takeda Pharmaceuticals CIS Insulin Product and Solutions
Table 40. Takeda Pharmaceuticals CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Oramed Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Oramed Pharmaceuticals CIS Insulin Major Business
Table 43. Oramed Pharmaceuticals CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 44. Oramed Pharmaceuticals SWOT Analysis
Table 45. Oramed Pharmaceuticals CIS Insulin Product and Solutions
Table 46. Oramed Pharmaceuticals CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Nanjing Xinbai Pharmaceutical Corporate Information, Location and Competitors
Table 48. Nanjing Xinbai Pharmaceutical CIS Insulin Major Business
Table 49. Nanjing Xinbai Pharmaceutical CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 50. Nanjing Xinbai Pharmaceutical SWOT Analysis
Table 51. Nanjing Xinbai Pharmaceutical CIS Insulin Product and Solutions
Table 52. Nanjing Xinbai Pharmaceutical CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Biocon Corporate Information, Location and Competitors
Table 54. Biocon CIS Insulin Major Business
Table 55. Biocon CIS Insulin Total Revenue (USD Million) (2017-2018)
Table 56. Biocon SWOT Analysis
Table 57. Biocon CIS Insulin Product and Solutions
Table 58. Biocon CIS Insulin Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global CIS Insulin Revenue (Million USD) by Players (2015-2020)
Table 60. Global CIS Insulin Revenue Share by Players (2015-2020)
Table 61. Global CIS Insulin Revenue (Million USD) by Regions (2015-2020)
Table 62. Global CIS Insulin Revenue Market Share by Regions (2015-2020)
Table 63. North America CIS Insulin Revenue by Countries (2015-2020)
Table 64. North America CIS Insulin Revenue Market Share by Countries (2015-2020)
Table 65. Europe CIS Insulin Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific CIS Insulin Revenue (Million USD) by Countries (2015-2020)
Table 67. South America CIS Insulin Revenue by Countries (2015-2020)
Table 68. South America CIS Insulin Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa CIS Insulin Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa CIS Insulin Revenue Market Share by Countries (2015-2020)
Table 71. Global CIS Insulin Revenue (Million USD) by Type (2015-2020)
Table 72. Global CIS Insulin Revenue Share by Type (2015-2020)
Table 73. Global CIS Insulin Revenue Forecast by Type (2021-2025)
Table 74. Global CIS Insulin Revenue by Application (2015-2020)
Table 75. Global CIS Insulin Revenue Share by Application (2015-2020)
Table 76. Global CIS Insulin Revenue Forecast by Application (2021-2025)
Table 77. Global CIS Insulin Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. CIS Insulin Picture
Figure 2. Global CIS Insulin Revenue Market Share by Type in 2019
Figure 3. Long-Acting Analog Picture
Figure 4. Rapid Acting Analog Picture
Figure 5. Premixed Analog Picture
Figure 6. Intermediate Insulin Picture
Figure 7. Short Acting Insulin Picture
Figure 8. Premixed Insulin Picture
Figure 9. CIS Insulin Revenue Market Share by Application in 2019
Figure 10. Type I and Other Diabetes Picture
Figure 11. Type II Diabetes Picture
Figure 12. Global CIS Insulin Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global CIS Insulin Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global CIS Insulin Revenue Share by Players in 2019
Figure 20. Global Top 5 Players CIS Insulin Revenue Market Share in 2019
Figure 21. Global Top 10 Players CIS Insulin Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global CIS Insulin Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global CIS Insulin Revenue Market Share by Regions (2015-2020)
Figure 25. Global CIS Insulin Revenue Market Share by Regions in 2018
Figure 26. North America CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 27. Europe CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 29. South America CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 31. North America CIS Insulin Revenue Market Share by Countries (2015-2020)
Figure 32. North America CIS Insulin Revenue Market Share by Countries in 2019
Figure 33. USA CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 34. Canada CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 35. Mexico CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 36. Europe CIS Insulin Revenue Market Share by Countries (2015-2020)
Figure 37. Europe CIS Insulin Revenue Market Share by Countries in 2019
Figure 38. Germany CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 39. UK CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 40. France CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 41. Russia CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 42. Italy CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific CIS Insulin Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific CIS Insulin Revenue Market Share by Countries in 2019
Figure 45. China CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 46. Japan CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 47. Korea CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 48. India CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 50. South America CIS Insulin Revenue Market Share by Countries (2015-2020)
Figure 51. South America CIS Insulin Revenue Market Share by Countries in 2019
Figure 52. Brazil CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 53. Argentina CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa CIS Insulin Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa CIS Insulin Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 57. UAE CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 58. Egypt CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 59. South Africa CIS Insulin Revenue and Growth Rate (2015-2020)
Figure 60. Global CIS Insulin Revenue Share by Type (2015-2020)
Figure 61. Global CIS Insulin Revenue Share by Type in 2019
Figure 62. Global CIS Insulin Market Share Forecast by Type (2021-2025)
Figure 63. Global Long-Acting Analog Revenue Growth Rate (2015-2020)
Figure 64. Global Rapid Acting Analog Revenue Growth Rate (2015-2020)
Figure 65. Global Premixed Analog Revenue Growth Rate (2015-2020)
Figure 66. Global Intermediate Insulin Revenue Growth Rate (2015-2020)
Figure 67. Global Short Acting Insulin Revenue Growth Rate (2015-2020)
Figure 68. Global Premixed Insulin Revenue Growth Rate (2015-2020)
Figure 69. Global CIS Insulin Revenue Share by Application (2015-2020)
Figure 70. Global CIS Insulin Revenue Share by Application in 2019
Figure 71. Global CIS Insulin Market Share Forecast by Application (2021-2025)
Figure 72. Global Type I and Other Diabetes Revenue Growth Rate (2015-2020)
Figure 73. Global Type II Diabetes Revenue Growth Rate (2015-2020)
Figure 74. Global CIS Insulin Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global CIS Insulin Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global CIS Insulin Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America CIS Insulin Revenue Market Forecast (2021-2025)
Figure 78. Europe CIS Insulin Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific CIS Insulin Revenue Market Forecast (2021-2025)
Figure 80. South America CIS Insulin Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa CIS Insulin Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
基礎インスリン（長時間作用型インスリン）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Basal Insulin (Long-Acting Insulin) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 糖尿病インスリンペンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Insulin Pen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Insulin Pen mar…
- 糖尿病インスリンポンプの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Diabetes Insulin Pumps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 獣医インスリン薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Veterinary Insulin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- インスリンポンプセンサーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Insulin Pump Sensor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Insulin Pump Sensor marke…